Viewing Study NCT01226056


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2025-12-25 @ 8:58 PM
Study NCT ID: NCT01226056
Status: SUSPENDED
Last Update Posted: 2010-10-21
First Post: 2010-10-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets
Sponsor: Southern Europe New Drug Organization
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module